Healthcare IT security company Imprivata has announced that WCA Hospital in Jamestown, New York is deploying its biometric Imprivata Confirm ID solution for secure electronic prescribing of controlled substances.Imprivata notes that its Confirm ID gives WCA a comprehensive platform for simplifying the DEA's provider identity proofing, credential enrollment, and auditing/reporting requirements for EPCS.Meanwhile, its two-factor authentication options (including fingerprint biometrics) to give WCA's providers a secure prescribing workflow.”Our objectives for EPCS were to improve provider efficiency, increase patient safety and satisfaction, and reduce the risk of fraud and drug diversion associated with paper-based prescriptions. But to get there, we needed a solution to help us address the complexities of the DEA requirements for EPCS without creating an onerous workflow for our providers,” said Laura Josephson, RN, clinical informatics manager at WCA Hospital.”Imprivata Confirm ID solves these challenges by giving us a comprehensive solution to streamline identity proofing and other EPCS requirements. Imprivata Confirm ID also gives us the flexibility to offer the two-factor authentication modalities that best fit our providers' workflows, which makes EPCS a fast, convenient process for our clinical staff. This has been critical to driving adoption and achieving success with our EPCS initiative.”The launches follows the news in August that Imprivata had launched a palm-vein scanning solution that creates a one-to-one link between patients and their correct medial record in their provider's electronic health record (EHR) system. In May, Imprivata acquired HT Systems, a provider of palm-vein based biometric patient identification systems.